Adial Pharmaceuticals (ADIL) Treasury Shares (2022 - 2026)
Adial Pharmaceuticals (ADIL) posted Treasury Shares of $1.2 million for Q1 2026, little changed sequentially from $1.2 million in Q4 2025, and down 70.48% YoY from $4.2 million in Q1 2025.
Adial Pharmaceuticals (ADIL) Treasury Shares (2022 - 2026) Analysis & Trends
Adial Pharmaceuticals has reported Treasury Shares for 5 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Treasury Shares fell 70.48% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 70.48% YoY) and the FY2025 annual result came in at $1.2 million, up 638.24% from the prior year.
- Treasury Shares steadied at $1.2 million in Q1 2026 per ADIL's latest filing, from $1.2 million in the prior quarter.
- Over five years, Treasury Shares peaked at $26.6 million in Q2 2025 and troughed at $168032.0 in Q4 2024.
- A 5-year average of $6.7 million and a median of $4.2 million in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2025 and 2026: Treasury Shares surged 638.24% in 2025, then plunged 70.48% in 2026.
- Over 5 years, Treasury Shares stood at $486726.0 in 2022, then tumbled by 65.29% to $168929.0 in 2023, then slipped by 0.53% to $168032.0 in 2024, then soared by 638.24% to $1.2 million in 2025, then changed by 0.0% to $1.2 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $1.2 million, $1.2 million, and $26.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Adial Pharmaceuticals | 29.02 Mn | 29.02 Mn | - | 12,930.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.24 Mn |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 26.47 Mn |
| Sep 30, 2025 | 26.47 Mn |
| Jun 30, 2025 | 26.61 Mn |
| Jun 30, 2025 | 26.61 Mn |
| Mar 31, 2025 | 4.20 Mn |
| Mar 31, 2025 | 4.20 Mn |
| Dec 31, 2024 | 168,032.00 |
| Dec 31, 2024 | 168,032.00 |
| Sep 30, 2024 | 4.20 Mn |
| Sep 30, 2024 | 4.20 Mn |
| Jun 30, 2024 | 4.20 Mn |
| Jun 30, 2024 | 4.20 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Dec 31, 2023 | 168,929.00 |
| Dec 31, 2023 | 168,929.00 |